Procaps Group S.A. (PROC)
1.76
0.08 (4.76%)
At close: Jan 14, 2025, 3:58 PM
undefined% (undefined)
| Bid | 1.7 |
| Market Cap | 198.57M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.52 |
| PE Ratio (ttm) | 3.38 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 1.8 |
| Volume | 9,344 |
| Avg. Volume (20D) | 103,144 |
| Open | 1.66 |
| Previous Close | 1.68 |
| Day's Range | 1.66 - 1.80 |
| 52-Week Range | 0.50 - 4.63 |
| Beta | undefined |
About PROC
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protecti...
Sector Healthcare
IPO Date Dec 9, 2019
Employees 5,500
Stock Exchange NASDAQ
Ticker Symbol PROC
Website https://www.procapsgroup.com
Analyst Forecast
According to 1 analyst ratings, the average rating for PROC stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
